Dr. King and Dr. Laurencin of Connecticut Institute for Clinical and Translational Science and the University of Connecticut opened the Food and Drug Administration (FDA) Commissioner Health Disparities Lectureship and gave a talk to employees addressing ways to consider race, culture and ethnicity in regulatory actions.  The FDA Commissioner Health Disparities Lectureship is the first lectureship of its kind.